Rhythm Biosciences (FRA:0RY) Long-Term Capital Lease Obligation : €0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Rhythm Biosciences Long-Term Capital Lease Obligation?

Rhythm Biosciences's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.00 Mil.

Rhythm Biosciences's annual Long-Term Capital Lease Obligation increased from Jun. 2021 (€0.00 Mil) to Jun. 2022 (€0.06 Mil) but then declined from Jun. 2022 (€0.06 Mil) to Jun. 2023 (€0.00 Mil).

Rhythm Biosciences Long-Term Capital Lease Obligation Historical Data

The historical data trend for Rhythm Biosciences's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Long-Term Capital Lease Obligation Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.06

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial								-	0.06	-	-	-

Rhythm Biosciences (FRA:0RY) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Rhythm Biosciences Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (FRA:0RY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (FRA:0RY) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

RHY:Australia

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (FRA:0RY) Headlines

No Headlines